Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CC transcript
|
|
Altus Pharmaceuticals Inc. (ALTU)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/16/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/16/2009 |
4
| PRESIDIO MANAGEMENT GROUP VIII L L C (10% Owner) has filed a Form 4 on Altus Pharmaceuticals Inc.|
Txns:
| Sold 293,611 shares
@ $0.3243, valued at
$95.2k
Sold 2,161 shares
@ $0.3243, valued at
$700.8
Sold 2,756 shares
@ $0.3243, valued at
$893.8
Sold 1,472 shares
@ $0.3243, valued at
$477.4 |
|
| 07/02/2009 |
4
| WYZGA MICHAEL S (Director) has filed a Form 4 on Altus Pharmaceuticals Inc. |
| 07/02/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 07/02/2009 |
4
| NAVIA MANUEL (Director) has filed a Form 4 on Altus Pharmaceuticals Inc. |
| 07/02/2009 |
4
| Richard John P (Director) has filed a Form 4 on Altus Pharmaceuticals Inc. |
| 07/02/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 04/20/2009 |
4
| WARBURG PINCUS PRIVATE EQUITY VIII L P (10% Owner) has filed a Form 4 on Altus Pharmaceuticals Inc. |
| 04/15/2009 |
4
| WARBURG PINCUS PRIVATE EQUITY VIII L P (10% Owner) has filed a Form 4 on Altus Pharmaceuticals Inc. |
| 02/23/2009 |
4
| GEMAYEL GEORGES (President & CEO) has filed a Form 4 on Altus Pharmaceuticals Inc. |
| 01/29/2009 |
4
| Phair Thomas J. (Sr. Dir, Finance & Controller) has filed a Form 4 on Altus Pharmaceuticals Inc. |
| 01/29/2009 |
4
| Porter Jill (VP, Process Dev & Engineering) has filed a Form 4 on Altus Pharmaceuticals Inc. |
| 01/29/2009 |
4
| Attie Kenneth (VP, Clinical Dev & Med Affairs) has filed a Form 4 on Altus Pharmaceuticals Inc. |
| 01/29/2009 |
4
| Gotwals Philip (VP, Program Management) has filed a Form 4 on Altus Pharmaceuticals Inc. |
| 01/29/2009 |
4
| GEMAYEL GEORGES (President & CEO) has filed a Form 4 on Altus Pharmaceuticals Inc. |
|
|